{"id":607,"date":"2012-11-01T16:12:05","date_gmt":"2012-11-01T15:12:05","guid":{"rendered":"http:\/\/www.gendiag.com\/missio-visio\/"},"modified":"2021-06-09T08:45:23","modified_gmt":"2021-06-09T07:45:23","slug":"missio-visio","status":"publish","type":"page","link":"https:\/\/www.gendiag.com\/ca\/companyia\/missio-visio\/","title":{"rendered":"Missi\u00f3-Visi\u00f3"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.9.4&#8243; custom_padding=&#8221;0px||0px||false|false&#8221;][et_pb_row _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#2b96cc&#8221; background_enable_image=&#8221;off&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat-x&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221;][et_pb_text _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h1 style=\"text-align: center;\">MISSI\u00d3-VISI\u00d3<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_5,3_5&#8243; admin_label=&#8221;row&#8221; _builder_version=&#8221;3.25&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/www.gendiag.com\/wp-content\/uploads\/2012\/11\/imagenMisionVision.jpg&#8221; title_text=&#8221;imagenMisionVision&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;3.25&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.9.4&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong>Gendiag<\/strong><span>\u00a0<\/span>transforma les oportunitats de projectes biotecnol\u00f2gics innovadors, sorgits de l\u2019\u00e0mbit acad\u00e8mic i de petites companyies biotecnol\u00f2giques, en productes i serveis que facilitin al professional sanitari les mesures de prevenci\u00f3, diagn\u00f2stic, pron\u00f2stic i resposta a f\u00e0rmacs que incideixin en una millora dels objectius terap\u00e8utics del tractament i de la qualitat de vida en pacients amb patologies d\u2019alt impacte sanitari.<\/p>\n<p><strong>Gendiag<\/strong><span>\u00a0<\/span>planteja el desenvolupaments i la comercialitzaci\u00f3 dels seus productes en un mercat global.<\/p>\n<p><strong>Gendiag<\/strong><span>\u00a0<\/span>transferir\u00e0 el seu coneixement a companyies del sector sanitari \u00a0per a la millora de la efici\u00e8ncia mitjan\u00e7ant l\u2019aplicaci\u00f3 d\u2019elements de gesti\u00f3 comercial, financera i de recerca i desenvolupament.<\/p>\n<p><strong>Gendiag<\/strong><span>\u00a0<\/span>participar\u00e0 en les plataformes de recerca, desenvolupament i innovaci\u00f3 de nous productes i serveis amb altres companyies del sector qu\u00edmic-farmac\u00e8utic i biotecnol\u00f2gic.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;28px&#8221; hover_enabled=&#8221;0&#8243; custom_css_main_element=&#8221;color: #1e73be;||    text-align: left;||    font-family: Abril Fatface;||    font-weight: 400;||    font-style: normal;&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>&#8220;Creiem en la prevenci\u00f3 \u2026<br \/>&#8230;contribu\u00efm a la salut de les persones&#8221;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MISSI\u00d3-VISI\u00d3Gendiag\u00a0transforma les oportunitats de projectes biotecnol\u00f2gics innovadors, sorgits de l\u2019\u00e0mbit acad\u00e8mic i de petites companyies biotecnol\u00f2giques, en productes i serveis que facilitin al professional sanitari les mesures de prevenci\u00f3, diagn\u00f2stic, pron\u00f2stic i resposta a f\u00e0rmacs que incideixin en una millora dels objectius terap\u00e8utics del tractament i de la qualitat de vida en pacients amb patologies [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":598,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"_links":{"self":[{"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/pages\/607"}],"collection":[{"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/comments?post=607"}],"version-history":[{"count":1,"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/pages\/607\/revisions"}],"predecessor-version":[{"id":2380,"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/pages\/607\/revisions\/2380"}],"up":[{"embeddable":true,"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/pages\/598"}],"wp:attachment":[{"href":"https:\/\/www.gendiag.com\/ca\/wp-json\/wp\/v2\/media?parent=607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}